Prescribing Information & Guidance


Bulletin 272 Gender Identity Services – Primary Care Prescribing Responsibilities for the Hormonal Treatments (including Eflornithine for the Treatment of Hirsutism in this setting) – JPC Position Statement


Bulletin 272 – Published Feb 2019, updated Dec 2021

View Document

Guideline Categories: Miscellaneous

Guideline Areas: Bedfordshire, Luton

Guideline Tags: eflornithine, gender, hirsutism, hormonal, hormone, identity, transgender

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net